Complement Alone Drives Efficacy of a Chimeric Antigonococcal Monoclonal Antibody

PLoS Biology - United States
doi 10.1371/journal.pbio.3000323
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Cancer Research
Cancer ResearchOncology
2005English

Development of a Chimeric Anti-Cd40 Monoclonal Antibody That Synergizes With LEA29Y to Prolong Islet Allograft Survival

Journal of Immunology
AllergyImmunology
2004English

Involvement ofN-Myristoylation in Monoclonal Antibody Recognition Sites on Chimeric G Protein Α Subunits

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Different Biodistribution of 99mTc-Labelled Chimeric Mouse-Human Monoclonal Antibody Between Athymic Mice Model and Human

British Journal of Cancer
Cancer ResearchOncology
1996English

A Monoclonal Thyroid-Stimulating Antibody

Journal of Clinical Investigation
Medicine
2002English

Monoclonal Antibody Therapy

AAOHN Journal
1987English

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2011English

Complement-Mediated Enhancement of Antibody Function for Neutralization of Pseudotype Virus Containing Hepatitis C Virus E2 Chimeric Glycoprotein

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2002English

Anti-Antibody Activity of a Monoclonal Macroglobulin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1971English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy